Eli Lilly posts robust Q4 earnings as Mounjaro and Zepbound sales more than double, lifting full-year revenue by 32% ...
3h
HealthDay on MSNPrescriptions for Obesity Management Drugs IncreasingPrescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with onli ...
They're known to aid in blood sugar control and, now, weight loss — but, according to a sweeping new study, the popular GLP-1 ...
Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance. The approach is especially popular among telemedicine physicians, who ...
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...
Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results